Clarice Lauer Schmidt

Title: Clarice Lauer Schmidt: Innovator in Gene Targeting Technologies

Introduction

Clarice Lauer Schmidt is a prominent inventor based in Des Moines, Iowa. She has made significant contributions to the field of genetic engineering, particularly in the area of gene targeting. Her innovative work has implications for various applications in biotechnology and medicine.

Latest Patents

Clarice holds a patent for her invention titled "TAL effector-mediated DNA modification." This patent focuses on materials and methods related to gene targeting, specifically utilizing transcription activator-like effector nucleases, commonly known as TALENs. This technology has opened new avenues for precise genetic modifications.

Career Highlights

Throughout her career, Clarice has worked with esteemed institutions such as the University of Minnesota and the Iowa State University Research Foundation, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field of genetic research.

Collaborations

Clarice has collaborated with notable colleagues, including Daniel F. Voytas and Adam J. Bogdanove. These partnerships have further enhanced her research and contributed to advancements in gene targeting technologies.

Conclusion

Clarice Lauer Schmidt's innovative work in gene targeting exemplifies the impact of her contributions to biotechnology. Her patent and collaborations highlight her role as a key figure in advancing genetic engineering.